《中国2型糖尿病防治指南(2020年版)》解读

2021-12-05 河北医科大学第四医院内分泌科河北医科大学学报

近年来,国内外对糖尿病及其并发症防治方面的研究进展迅速,循证证据不断增多,新药尤其是有心血管获益证据的新药开发突飞猛进。

中文标题：

发布机构：

河北医科大学第四医院内分泌科

发布日期：

2021-12-05

简要介绍：

近年来,国内外对糖尿病及其并发症防治方面的研究进展迅速,循证证据不断增多,新药尤其是有心血管获益证据的新药开发突飞猛进。为及时传递糖尿病防治的重要进展,更好指导临床,中华医学会糖尿病学分会对原指南进行了修订,发布了具有多点里程碑意义进展的《中国2型糖尿病防治指南(2020年版)》。对指导我国2型糖尿病防治,规范临床综合管理,减少糖尿病的危害具有重要的指导意义。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=1e4461c00233a830, title=《中国2型糖尿病防治指南(2020年版)》解读, enTitle=, guiderFrom=河北医科大学学报, authorId=0, author=, summary=近年来,国内外对糖尿病及其并发症防治方面的研究进展迅速,循证证据不断增多,新药尤其是有心血管获益证据的新药开发突飞猛进。, cover=https://img.medsci.cn/2022123/1642944512697_5579292.jpg, journalId=0, articlesId=null, associationId=2347, associationName=河北医科大学第四医院内分泌科, associationIntro=河北医科大学第四医院内分泌科, copyright=0, guiderPublishedTime=Sun Dec 05 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">近年来,国内外对糖尿病及其并发症防治方面的研究进展迅速,循证证据不断增多,新药尤其是有心血管获益证据的新药开发突飞猛进。为及时传递糖尿病防治的重要进展,更好指导临床,中华医学会糖尿病学分会对原指南进行了修订,发布了具有多点里程碑意义进展的《中国2型糖尿病防治指南(2020年版)》。对指导我国2型糖尿病防治,规范临床综合管理,减少糖尿病的危害具有重要的指导意义。 </span></p>, tagList=[TagDto(tagId=216, tagName=糖尿病), TagDto(tagId=2052, tagName=2型糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5889, appHits=526, showAppHits=0, pcHits=982, showPcHits=5359, likes=1, shares=81, comments=4, approvalStatus=1, publishedTime=Sun Jan 23 21:25:29 CST 2022, publishedTimeString=2021-12-05, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sun Jan 23 21:30:11 CST 2022, updatedBy=4754896, updatedName=小小医者, updatedTime=Fri Jan 05 23:19:54 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《中国2型糖尿病防治指南(2020年版)》解读.pdf)])

《中国2型糖尿病防治指南(2020年版)》解读.pdf

下载请点击：

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1219058, encodeId=9446121905857, content=学习学习再学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:41:09 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206745, encodeId=83011206e45b1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f825633095, createdName=ms5000001254633344, createdTime=Mon Mar 28 23:17:53 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198002, encodeId=103411980027b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82415144047, createdName=14681314m52暂无昵称, createdTime=Mon Feb 28 13:43:29 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194989, encodeId=e500119498914, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Sat Feb 19 09:26:27 CST 2022, time=2022-02-19, status=1, ipAttribution=)]
2022-05-12 湘雅科教

学习学习再学习！

0 0
[GetPortalCommentsPageByObjectIdResponse(id=1219058, encodeId=9446121905857, content=学习学习再学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:41:09 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206745, encodeId=83011206e45b1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f825633095, createdName=ms5000001254633344, createdTime=Mon Mar 28 23:17:53 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198002, encodeId=103411980027b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82415144047, createdName=14681314m52暂无昵称, createdTime=Mon Feb 28 13:43:29 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194989, encodeId=e500119498914, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Sat Feb 19 09:26:27 CST 2022, time=2022-02-19, status=1, ipAttribution=)]
2022-03-28 ms5000001254633344

学习了

52 0
[GetPortalCommentsPageByObjectIdResponse(id=1219058, encodeId=9446121905857, content=学习学习再学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:41:09 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206745, encodeId=83011206e45b1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f825633095, createdName=ms5000001254633344, createdTime=Mon Mar 28 23:17:53 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198002, encodeId=103411980027b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82415144047, createdName=14681314m52暂无昵称, createdTime=Mon Feb 28 13:43:29 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194989, encodeId=e500119498914, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Sat Feb 19 09:26:27 CST 2022, time=2022-02-19, status=1, ipAttribution=)]
2022-02-28 14681314m52暂无昵称

很好

56 0
[GetPortalCommentsPageByObjectIdResponse(id=1219058, encodeId=9446121905857, content=学习学习再学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:41:09 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206745, encodeId=83011206e45b1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f825633095, createdName=ms5000001254633344, createdTime=Mon Mar 28 23:17:53 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198002, encodeId=103411980027b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82415144047, createdName=14681314m52暂无昵称, createdTime=Mon Feb 28 13:43:29 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194989, encodeId=e500119498914, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Sat Feb 19 09:26:27 CST 2022, time=2022-02-19, status=1, ipAttribution=)]
2022-02-19 123a16c8m00暂无昵称

受益匪浅

46 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

内分泌指南

《中国2型糖尿病防治指南(2020年版)》解读

相关指南

科室

工具

服务